about
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases suc...
Read More
14.05
-0.01
(-0.07%)
4.0M
XNAS Volume
High volume today
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Climb Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..